By Izzy Wood (Drug Target Review)2023-04-12T16:02:32
With advancements in artificial intelligence, precision medicine and gene editing, the field of drug discovery is undergoing a rapid transformation. In this article, Drug Target Review’s Izzy Wood gets the insider knowledge from industry leaders at SLAS 2023, who are experiencing these changes first hand.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T06:15:00Z
Contributor Professor Donald E Ingber, By Drug Target Review
2026-07-08T12:00:00Z
2026-07-08T07:58:00Z
Contributor Dr Nick Lynch, By Dr Raminderpal Singh
2026-06-15T07:00:00
Contributor Professor Dipak Ramji, By Drug Target Review
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-05-30T13:51:56
Sponsored by BPS Bioscience
2024-01-26T13:22:42
Sponsored by bit.bio
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
Site powered by Webvision Cloud